120 related articles for article (PubMed ID: 33311590)
1. Comment on "Identification of EMT-related high-risk stage II colorectal cancer and characterisation of metastasis-related genes".
Loughrey MB; Fisher NC; McCooey AJ; Dunne PD
Br J Cancer; 2021 Mar; 124(6):1175-1176. PubMed ID: 33311590
[No Abstract] [Full Text] [Related]
2. Identification of EMT-related high-risk stage II colorectal cancer and characterisation of metastasis-related genes.
Wang K; Song K; Ma Z; Yao Y; Liu C; Yang J; Xiao H; Zhang J; Zhang Y; Zhao W
Br J Cancer; 2020 Aug; 123(3):410-417. PubMed ID: 32435058
[TBL] [Abstract][Full Text] [Related]
3. Genomics and prognosis analysis of epithelial-mesenchymal transition in colorectal cancer patients.
Zhang Z; Zheng S; Lin Y; Sun J; Ding N; Chen J; Zhong J; Shi L; Xue M
BMC Cancer; 2020 Nov; 20(1):1135. PubMed ID: 33228590
[TBL] [Abstract][Full Text] [Related]
4. Epithelial-to-mesenchymal transition signature assessment in colorectal cancer quantifies tumour stromal content rather than true transition.
McCorry AM; Loughrey MB; Longley DB; Lawler M; Dunne PD
J Pathol; 2018 Dec; 246(4):422-426. PubMed ID: 30105762
[TBL] [Abstract][Full Text] [Related]
5. IGFBP-rP1 suppresses epithelial-mesenchymal transition and metastasis in colorectal cancer.
Zhu S; Zhang J; Xu F; Xu E; Ruan W; Ma Y; Huang Q; Lai M
Cell Death Dis; 2015 Mar; 6(3):e1695. PubMed ID: 25789970
[TBL] [Abstract][Full Text] [Related]
6. MicroRNA-200c modulates epithelial-to-mesenchymal transition (EMT) in human colorectal cancer metastasis.
Hur K; Toiyama Y; Takahashi M; Balaguer F; Nagasaka T; Koike J; Hemmi H; Koi M; Boland CR; Goel A
Gut; 2013 Sep; 62(9):1315-26. PubMed ID: 22735571
[TBL] [Abstract][Full Text] [Related]
7. Long non-coding RNA (lncRNA) and epithelial-mesenchymal transition (EMT) in colorectal cancer: a systematic review.
O'Brien SJ; Bishop C; Hallion J; Fiechter C; Scheurlen K; Paas M; Burton J; Galandiuk S
Cancer Biol Ther; 2020 Sep; 21(9):769-781. PubMed ID: 32730165
[TBL] [Abstract][Full Text] [Related]
8. GRHL2 inhibits colorectal cancer progression and metastasis via oppressing epithelial-mesenchymal transition.
Yang Z; Wu D; Chen Y; Min Z; Quan Y
Cancer Biol Ther; 2019; 20(9):1195-1205. PubMed ID: 31063022
[TBL] [Abstract][Full Text] [Related]
9. LncRNA TUG1 promoted KIAA1199 expression via miR-600 to accelerate cell metastasis and epithelial-mesenchymal transition in colorectal cancer.
Sun J; Hu J; Wang G; Yang Z; Zhao C; Zhang X; Wang J
J Exp Clin Cancer Res; 2018 May; 37(1):106. PubMed ID: 29776371
[TBL] [Abstract][Full Text] [Related]
10. 20(S)-Protopanaxadiol inhibits epithelial-mesenchymal transition by promoting retinoid X receptor alpha in human colorectal carcinoma cells.
Lu Z; Liu H; Fu W; Wang Y; Geng J; Wang Y; Yu X; Wang Q; Xu H; Sui D
J Cell Mol Med; 2020 Dec; 24(24):14349-14365. PubMed ID: 33128348
[TBL] [Abstract][Full Text] [Related]
11. PBX3 Is Part of an EMT Regulatory Network and Indicates Poor Outcome in Colorectal Cancer.
Lamprecht S; Kaller M; Schmidt EM; Blaj C; Schiergens TS; Engel J; Jung A; Hermeking H; Grünewald TGP; Kirchner T; Horst D
Clin Cancer Res; 2018 Apr; 24(8):1974-1986. PubMed ID: 29391352
[No Abstract] [Full Text] [Related]
12. Rufy3 promotes metastasis through epithelial-mesenchymal transition in colorectal cancer.
Xie R; Wang J; Tang W; Li Y; Peng Y; Zhang H; Liu G; Huang X; Zhao J; Li A; Gong W; Chen Y; Ren Y; Wang Y; Li G; Liu S; Wang J
Cancer Lett; 2017 Apr; 390():30-38. PubMed ID: 28089833
[TBL] [Abstract][Full Text] [Related]
13. Down-regulation of aquaporin 5-mediated epithelial-mesenchymal transition and anti-metastatic effect by natural product Cairicoside E in colorectal cancer.
Chen C; Ma T; Zhang C; Zhang H; Bai L; Kong L; Luo J
Mol Carcinog; 2017 Dec; 56(12):2692-2705. PubMed ID: 28833571
[TBL] [Abstract][Full Text] [Related]
14. MiR-29c mediates epithelial-to-mesenchymal transition in human colorectal carcinoma metastasis via PTP4A and GNA13 regulation of β-catenin signaling.
Zhang JX; Mai SJ; Huang XX; Wang FW; Liao YJ; Lin MC; Kung HF; Zeng YX; Xie D
Ann Oncol; 2014 Nov; 25(11):2196-2204. PubMed ID: 25193986
[TBL] [Abstract][Full Text] [Related]
15. Antagonistic Effects of p53 and HIF1A on microRNA-34a Regulation of PPP1R11 and STAT3 and Hypoxia-induced Epithelial to Mesenchymal Transition in Colorectal Cancer Cells.
Li H; Rokavec M; Jiang L; Horst D; Hermeking H
Gastroenterology; 2017 Aug; 153(2):505-520. PubMed ID: 28435028
[TBL] [Abstract][Full Text] [Related]
16. MicroRNA-302c represses epithelial-mesenchymal transition and metastasis by targeting transcription factor AP-4 in colorectal cancer.
Ma W; Liu B; Li J; Jiang J; Zhou R; Huang L; Li X; He X; Zhou Q
Biomed Pharmacother; 2018 Sep; 105():670-676. PubMed ID: 29906744
[TBL] [Abstract][Full Text] [Related]
17. Research Progress of Epithelial-mesenchymal Transition Treatment and Drug Resistance in Colorectal Cancer.
Ni Q; Li M; Yu S
Technol Cancer Res Treat; 2022; 21():15330338221081219. PubMed ID: 35435774
[TBL] [Abstract][Full Text] [Related]
18. Tn antigen promotes human colorectal cancer metastasis via H-Ras mediated epithelial-mesenchymal transition activation.
Liu Z; Liu J; Dong X; Hu X; Jiang Y; Li L; Du T; Yang L; Wen T; An G; Feng G
J Cell Mol Med; 2019 Mar; 23(3):2083-2092. PubMed ID: 30637914
[TBL] [Abstract][Full Text] [Related]
19. MiR-363-3p inhibits the epithelial-to-mesenchymal transition and suppresses metastasis in colorectal cancer by targeting Sox4.
Hu F; Min J; Cao X; Liu L; Ge Z; Hu J; Li X
Biochem Biophys Res Commun; 2016 May; 474(1):35-42. PubMed ID: 27084453
[TBL] [Abstract][Full Text] [Related]
20. SIRT1 promotes epithelial-mesenchymal transition and metastasis in colorectal cancer by regulating Fra-1 expression.
Cheng F; Su L; Yao C; Liu L; Shen J; Liu C; Chen X; Luo Y; Jiang L; Shan J; Chen J; Zhu W; Shao J; Qian C
Cancer Lett; 2016 Jun; 375(2):274-283. PubMed ID: 26975631
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
